Literature DB >> 28824258

Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Insufficient Evidence to Support the Use of Hydroxyethyl Starch.

Christian J Wiedermann1, Andrea Piccin2, Giosue Gulli3.   

Abstract

Entities:  

Year:  2017        PMID： 28824258      PMCID： PMC5544654          DOI： 10.1007/s12288-017-0833-9

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  8 in total

1.  The Canadian apheresis registry.

Authors:  G Rock; B Clark; D Sutton
Journal:  Transfus Apher Sci       Date:  2003-10       Impact factor: 1.764

2.  Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases.

Authors:  Anil Tombak; Mehmet Ali Uçar; Aydan Akdeniz; Arda Yilmaz; Hakan Kaleagası; Mehmet Ali Sungur; Eyup Naci Tiftik
Journal:  Indian J Hematol Blood Transfus       Date:  2016-02-22       Impact factor: 0.900

3.  Washout kinetics of colloidal starch as a partial or full replacement for plasma exchange.

Authors:  M E Brecher; H G Owen
Journal:  J Clin Apher       Date:  1996       Impact factor: 2.821

4.  Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology.

Authors:  C Howell; K Douglas; G Cho; K El-Ghariani; P Taylor; D Potok; T Rintala; S Watkins
Journal:  Transfus Med       Date:  2015-04       Impact factor: 2.019

Review 5.  Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.

Authors:  Joseph Schwartz; Anand Padmanabhan; Nicole Aqui; Rasheed A Balogun; Laura Connelly-Smith; Meghan Delaney; Nancy M Dunbar; Volker Witt; Yanyun Wu; Beth H Shaz
Journal:  J Clin Apher       Date:  2016-06       Impact factor: 2.821

6.  Acquired lysosomal storage caused by frequent plasmapheresis procedures with hydroxyethyl starch.

Authors:  Johannes J A Auwerda; Frank W G Leebeek; J H Paul Wilson; Otto P van Diggelen; King H Lam; Pieter Sonneveld
Journal:  Transfusion       Date:  2006-10       Impact factor: 3.157

7.  Concerns over use of hydroxyethyl starch solutions.

Authors:  Christiane S Hartog; Charles Natanson; Junfeng Sun; Harvey G Klein; Konrad Reinhart
Journal:  BMJ       Date:  2014-11-10

Review 8.  Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review.

Authors:  Christian J Wiedermann; Michael Joannidis
Journal:  Intensive Care Med       Date:  2013-11-21       Impact factor: 17.440
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.